Molecular causes of the aberrant choline phospholipid metabolism in breast cancer.
about
Human breast cancer tissues contain abundant phosphatidylcholine(36∶1) with high stearoyl-CoA desaturase-1 expressionApplications of metabolomics in cancer researchProton MR spectroscopy in metabolic assessment of musculoskeletal lesionsCholine metabolism-based molecular diagnosis of cancer: an updateGlycerophosphocholine-dependent growth requires Gde1p (YPL110c) and Git1p in Saccharomyces cerevisiae.Comparison of the cellular and biochemical properties of Plasmodium falciparum choline and ethanolamine kinasesKey Players in Choline Metabolic Reprograming in Triple-Negative Breast CancerOmeprazole inhibits proliferation and modulates autophagy in pancreatic cancer cellsHDAC inhibition induces increased choline uptake and elevated phosphocholine levels in MCF7 breast cancer cellsDownregulation of Choline Kinase-Alpha Enhances Autophagy in Tamoxifen-Resistant Breast Cancer CellsCholine-releasing glycerophosphodiesterase EDI3 drives tumor cell migration and metastasisAdiabatic multi-echo ³¹P spectroscopic imaging (AMESING) at 7 T for the measurement of transverse relaxation times and regaining of sensitivity in tissues with short T₂ values.Determination of lipidomic differences between human breast cancer and surrounding normal tissues using HILIC-HPLC/ESI-MS and multivariate data analysis.The response of RIF-1 fibrosarcomas to the vascular-disrupting agent ZD6126 assessed by in vivo and ex vivo 1H magnetic resonance spectroscopy.CEST-MRI detects metabolite levels altered by breast cancer cell aggressiveness and chemotherapy responseA mixture model approach to the tests of concordance and discordance between two large-scale experiments with two-sample groups.Analysis of the human kinome using methods including fold recognition reveals two novel kinasesBiochemical characterization of breast tumors by in vivo and in vitro magnetic resonance spectroscopy (MRS)Inhibition of phosphatidylcholine-specific phospholipase C downregulates HER2 overexpression on plasma membrane of breast cancer cells.Epigenetic repression of phosphatidylethanolamine N-methyltransferase (PEMT) in BRCA1-mutated breast cancer.Distinct choline metabolic profiles are associated with differences in gene expression for basal-like and luminal-like breast cancer xenograft modelsActivation of phosphatidylcholine cycle enzymes in human epithelial ovarian cancer cells.Is there an association between enhanced choline and β-catenin pathway in breast cancer? A pilot study by MR Spectroscopy and ELISA.Quantitative measurement of organic acids in tissues from gastric cancer patients indicates increased glucose metabolism in gastric cancer.Multimodal mass spectrometric imaging of small molecules reveals distinct spatio-molecular signatures in differentially metastatic breast tumor models.Merging transcriptomics and metabolomics--advances in breast cancer profiling.PSMA-targeted theranostic nanoplex for prostate cancer therapy.Investigation of discriminant metabolites in tamoxifen-resistant and choline kinase-alpha-downregulated breast cancer cells using 1H-nuclear magnetic resonance spectroscopy.Metabolomics Identifies Metabolic Markers of Maturation in Human Pluripotent Stem Cell-Derived Cardiomyocytes.Molecular Effects of Doxorubicin on Choline Metabolism in Breast Cancer.Metabolic Portraits of Breast Cancer by HR MAS MR Spectroscopy of Intact Tissue Samples.Breast Tissue Metabolism by Magnetic Resonance Spectroscopy.Cholesterol sulfate imaging in human prostate cancer tissue by desorption electrospray ionization mass spectrometryMagnetic resonance spectroscopy in metabolic and molecular imaging and diagnosis of cancerMR-visible lipids and the tumor microenvironmentThe phosphoinositide 3-kinase inhibitor PI-103 downregulates choline kinase alpha leading to phosphocholine and total choline decrease detected by magnetic resonance spectroscopy.In vivo MRS of locally advanced breast cancer: characteristics related to negative or positive choline detection and early monitoring of treatment response.Glycerophosphodiester phosphodiesterase domain containing 5 (GDPD5) expression correlates with malignant choline phospholipid metabolite profiles in human breast cancerCharacterization of breast cancers and therapy response by MRS and quantitative gene expression profiling in the choline pathway.Hypoxic tumor microenvironments reduce collagen I fiber density
P2860
Q21090768-D0BBD748-6B56-476F-9668-2C144BCD4A89Q24600728-FA2B8194-F826-4437-99A2-54A040285EC5Q26851361-6FDB35F7-84BA-4519-BAC0-4C0A353904F0Q27024079-E7D15359-4C9C-4974-BB8B-CE67958F9A81Q27932923-CFF34642-E2E9-4411-87FB-851C1A1C667AQ27972958-142C3F65-3F8A-4A90-80FA-E12CAAC550C0Q28074613-AA98768C-8AEA-415B-9137-F74E432B86F7Q28478262-9D2D9609-26F9-496C-8C59-07D2015EDE04Q28486529-E5F9DF34-876C-4CF2-963A-A2B591E4FBBEQ28550472-8DE375AD-2A67-4E41-B7B0-54D375D75142Q30514230-DDBBA7A4-663A-402F-AD2C-3870543F73ECQ30611800-BC5ABB77-4209-44D6-AB65-2B6B49DBFD97Q30865106-88787EDF-EA1F-407B-8FB8-2A9D028A0B13Q31049713-F0F910A3-B5F1-4C10-8F30-E18AC16FC98CQ31082468-3AA22C3D-7CB0-41DB-8B92-B40710BA4C61Q33279912-6ADE6498-1C07-45F4-9447-1B9285DEFC1DQ33319571-36578804-1A72-4D6C-99AB-C38B91A19EE6Q33552272-EBCAF1F5-4611-4CFF-ABF9-F22411F66416Q33576337-E4C07B93-3A2A-4124-A0D2-92408B2F5635Q33576891-341F0C10-8682-49F1-9AF2-6A7D6202B7CFQ33660965-0DE9D8C3-F648-430D-9561-57BB2EF06B65Q33699139-C06ACE3B-802B-49AB-B683-01EE9EC8EE56Q33714951-5E732F8B-16C7-4264-A7C0-9B4AAB41E6E1Q33727137-D70921F1-70CA-4449-A2B7-2C007D1D7A48Q33736511-B53DB597-260C-4A0C-BB88-69B31BC3D1DFQ33748176-27B8D0A3-052D-4972-88D1-E4C7B3DF729EQ33791366-0BB70C99-5BF9-490E-952C-951CBB28949FQ33828887-BC40425F-8B11-4B03-853D-8C1E6BDA0A64Q33836433-0490EC59-D5ED-402E-9E1E-6E6E7D3D03F5Q33842777-1C10499A-2F83-47E5-96A7-3BB2CA132804Q33844930-59790C52-193F-41A6-9251-3174B0D231F3Q33844954-9925FC92-757A-4A6D-A228-0937F82995ECQ33858266-D89F79A7-2ACE-4413-A709-F58F26452341Q33881902-60C2B09D-F7F8-4DD9-8D52-7CE58C7DAE57Q33888362-B91AE57C-FB64-4598-92EE-36A5D84DD39EQ33959529-E8E7658F-A649-40E3-9913-5BA4757AD9A8Q34016780-A8E312F8-D759-441D-A8DE-98469E723544Q34020037-595DE201-1D41-4761-915A-C94CF90CE5E9Q34035237-1DC54ED9-1DB5-4CC1-857C-F91055C45F19Q34041303-0B07C2A4-3B31-48CF-8BEC-A729B3C18BCB
P2860
Molecular causes of the aberrant choline phospholipid metabolism in breast cancer.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Molecular causes of the aberrant choline phospholipid metabolism in breast cancer.
@ast
Molecular causes of the aberrant choline phospholipid metabolism in breast cancer.
@en
type
label
Molecular causes of the aberrant choline phospholipid metabolism in breast cancer.
@ast
Molecular causes of the aberrant choline phospholipid metabolism in breast cancer.
@en
prefLabel
Molecular causes of the aberrant choline phospholipid metabolism in breast cancer.
@ast
Molecular causes of the aberrant choline phospholipid metabolism in breast cancer.
@en
P2093
P1433
P1476
Molecular causes of the aberrant choline phospholipid metabolism in breast cancer.
@en
P2093
Chunfa Jie
Kristine Glunde
Zaver M Bhujwalla
P304
P356
10.1158/0008-5472.CAN-03-3829
P407
P577
2004-06-01T00:00:00Z